Low-dose inhaled fluticasone propionate versus oral zafirlukast in asthma patients

被引：0
|
作者：
Busse, W [1 ]
Srebro, SH [1 ]
Edwards, L [1 ]
Johnson, MC [1 ]
Rickard, K [1 ]
机构：
[1] Glaxo Wellcome, Res Triangle Pk, NC 27709 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A628 / A628
页数：1
相关论文
共 50 条
  • [1] Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
    Bleecker, ER
    Welch, MJ
    Weinstein, SF
    Kalberg, C
    Johnson, M
    Edwards, L
    Rickard, KA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) : 1123 - 1129
  • [2] Better asthma symptom control with low-dose inhaled fluticasone propionate than with oral zafirlukast
    Storms, W
    Srebro, SH
    Edwards, L
    Johnson, MC
    Rickard, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A628 - A628
  • [3] Greater improvement in pulmonary function with low-dose inhaled fluticasone propionate as compared with oral zafirlukast in patients with persistent asthma
    Weinstein, S
    Kalberg, C
    Edwards, L
    Johnson, M
    Rickard, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S14 - S14
  • [4] The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast
    Lanz, MJ
    Eisenlohr, C
    Llabre, MM
    Toledo, Y
    Lanz, MA
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (04) : 283 - 288
  • [5] Low-dose fluticasone versus zafirlukast in patients with persistent asthma.
    Bleecker, E
    Kalberg, C
    Edwards, L
    Rickard, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A630 - A630
  • [6] Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma
    Brabson, JH
    Clifford, D
    Kerwin, E
    Raphael, G
    Pepsin, PJ
    Edwards, LD
    Srebro, S
    Rickard, K
    AMERICAN JOURNAL OF MEDICINE, 2002, 113 (01): : 15 - 21
  • [7] Switching asthma patients from low dose inhaled corticosteroids to low dose fluticasone or zafirlukast
    Dvorin, DJ
    Pepsin, PJ
    Srebro, S
    Edwards, L
    Bowers, B
    Rickard, KA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S260 - S260
  • [8] Cost efficacy of an inhaled corticosteroid, fluticasone propionate, and an oral leukotriene modifier, zafirlukast, in patients with persistent asthma
    Menendez, R
    Carranza-Rosenzweig, J
    Stanford, R
    Bowers, B
    Edwards, L
    Kalberg, C
    Rickard, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S13 - S13
  • [9] A cost effectiveness analysis of inhaled fluticasone propionate (Flovent®) versus zafirlukast (Accolate®) in the treatment of patients with persistent asthma
    Rosenzweig, JC
    Bowers, B
    Edwards, L
    Stanford, R
    Srebro, S
    Rickard, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A760 - A760
  • [10] Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy
    Kim, KT
    Ginchansky, EJ
    Friedman, BF
    Srebro, S
    Pepsin, PJ
    Edwards, L
    Stanford, RH
    Rickard, K
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (05) : 398 - 406
12345